Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine, in comparison to a placebo control, the response to two dosage strengths of a topical gel formulation of nitroglycerin, MQX-303, in the determination of finger blood flow and skin temperature in the fingers of patients with moderate to severe Raynaud's phenomenon, follwoing exposure to cold temperatures.

Blood flow is determined by scanning laser Doppler equipment and skin temperature is measured using attached thermistor probes. Following baseline measurements, the study gel is applied, the hand is placed in a cold chamber, and then blood flow and skin temperature are monitored for the next two hours.

Each patient will receive multiple doses on different days so that each can serve as his/her own control in interpreting the response.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00253331
Study type Interventional
Source MediQuest Therapeutics
Contact
Status Completed
Phase Phase 2/Phase 3
Start date November 2004
Completion date September 2005

See also
  Status Clinical Trial Phase
Completed NCT01926847 - Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator Phase 2
Completed NCT03699436 - Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon N/A
Terminated NCT02374320 - Exparel as a Nerve Block for Severe Hand Pain Phase 2/Phase 3
Completed NCT00251238 - Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon Phase 2
Recruiting NCT02183779 - PORH and Response to Cold in Raynaud's Phenomenon. N/A
Active, not recruiting NCT00934427 - Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms Phase 3
Completed NCT02506062 - A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) N/A
Terminated NCT02642146 - Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study
Completed NCT01743612 - Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis. N/A
Completed NCT03094910 - Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon N/A
Recruiting NCT02298777 - Metabolomic Analysis of Systemic Sclerosis
Completed NCT00626665 - Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma Phase 3
Completed NCT00004786 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis Phase 3
Withdrawn NCT04898036 - Phototherapy For Treatment Of Raynaud's Phenomenon N/A
Completed NCT03027674 - Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud N/A
Terminated NCT03869008 - Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena. N/A